ASGLY's biopharmaceutical CDMO subsidiary, AGC Biologics, signed an agreement with Novartis AG's (NVS) Novartis Gene Therapies to purchase a cell and gene ...
https://www.google.com/url?rct=j&sa=t&url=https://stocknews.com/news/asgly-isuzy-icl-man-4-mid-cap-stocks-to-buy-right-now/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFJtfi16pMEfrH_MfqiTodQ-PAUKA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.